The proteasome activator 11 S REG (PA28) and class I antigen presentation - PubMed (original) (raw)
Review
. 2000 Jan 1;345 Pt 1(Pt 1):1-15.
Affiliations
- PMID: 10600633
- PMCID: PMC1220724
Review
The proteasome activator 11 S REG (PA28) and class I antigen presentation
M Rechsteiner et al. Biochem J. 2000.
Abstract
There are two immune responses in vertebrates: humoral immunity is mediated by circulating antibodies, whereas cytotoxic T lymphocytes (CTL) confer cellular immunity. CTL lyse infected cells upon recognition of cell-surface MHC Class I molecules complexed with foreign peptides. The displayed peptides are produced in the cytosol by degradation of host proteins or proteins from intracellular pathogens that might be present. Proteasomes are cylindrical multisubunit proteases that generate many of the peptides eventually transferred to the cell surface for immune surveillance. In mammalian proteasomes, six active sites face a central chamber. As this chamber is sealed off from the enzyme's surface, there must be mechanisms to promote entry of substrates. Two protein complexes have been found to bind the ends of the proteasome and activate it. One of the activators is the 19 S regulatory complex of the 26 S proteasome; the other activator is '11 S REG' [Dubiel, Pratt, Ferrell and Rechsteiner (1992) J. Biol. Chem. 267, 22369-22377] or 'PA28' [Ma, Slaughter and DeMartino (1992) J. Biol. Chem. 267, 10515-10523]. During the past 7 years, our understanding of the structure of REG molecules has increased significantly, but much less is known about their biological functions. There are three REG subunits, namely alpha, beta and gamma. Recombinant REGalpha forms a ring-shaped heptamer of known crystal structure. 11 S REG is a heteroheptamer of alpha and beta subunits. REGgamma is also presumably a heptameric ring, and it is found in the nuclei of the nematode work Caenorhabditis elegans and higher organisms, where it may couple proteasomes to other nuclear components. REGalpha and REGbeta, which are abundant in vertebrate immune tissues, are located mostly in the cytoplasm. Synthesis of REG alpha and beta subunits is induced by interferon-gamma, and this has led to the prevalent hypothesis that REG alpha/beta hetero-oligomers play an important role in Class I antigen presentation. In the present review we focus on the structural properties of REG molecules and on the evidence that REGalpha/beta functions in the Class I immune response.
Similar articles
- Structure of the proteasome activator REGalpha (PA28alpha).
Knowlton JR, Johnston SC, Whitby FG, Realini C, Zhang Z, Rechsteiner M, Hill CP. Knowlton JR, et al. Nature. 1997 Dec 11;390(6660):639-43. doi: 10.1038/37670. Nature. 1997. PMID: 9403698 - Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.
Brooks P, Fuertes G, Murray RZ, Bose S, Knecht E, Rechsteiner MC, Hendil KB, Tanaka K, Dyson J, Rivett J. Brooks P, et al. Biochem J. 2000 Feb 15;346 Pt 1(Pt 1):155-61. Biochem J. 2000. PMID: 10657252 Free PMC article. - The role of the proteasome system and the proteasome activator PA28 complex in the cellular immune response.
Kloetzel PM, Soza A, Stohwasser R. Kloetzel PM, et al. Biol Chem. 1999 Mar;380(3):293-7. doi: 10.1515/BC.1999.040. Biol Chem. 1999. PMID: 10223331 Review. - The components of the proteasome system and their role in MHC class I antigen processing.
Krüger E, Kuckelkorn U, Sijts A, Kloetzel PM. Krüger E, et al. Rev Physiol Biochem Pharmacol. 2003;148:81-104. doi: 10.1007/s10254-003-0010-4. Epub 2003 Mar 25. Rev Physiol Biochem Pharmacol. 2003. PMID: 12687403 Review.
Cited by
- Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways.
Raynes R, Pomatto LC, Davies KJ. Raynes R, et al. Mol Aspects Med. 2016 Aug;50:41-55. doi: 10.1016/j.mam.2016.05.001. Epub 2016 May 4. Mol Aspects Med. 2016. PMID: 27155164 Free PMC article. Review. - Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.
Keppler BR, Archer TK, Kinyamu HK. Keppler BR, et al. Biochim Biophys Acta. 2011 Feb;1809(2):109-18. doi: 10.1016/j.bbagrm.2010.08.005. Epub 2010 Aug 20. Biochim Biophys Acta. 2011. PMID: 20728592 Free PMC article. Review. - Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein.
Moriishi K, Okabayashi T, Nakai K, Moriya K, Koike K, Murata S, Chiba T, Tanaka K, Suzuki R, Suzuki T, Miyamura T, Matsuura Y. Moriishi K, et al. J Virol. 2003 Oct;77(19):10237-49. doi: 10.1128/jvi.77.19.10237-10249.2003. J Virol. 2003. PMID: 12970408 Free PMC article. - Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.
Vigneron N, Van den Eynde BJ. Vigneron N, et al. Biomolecules. 2014 Nov 18;4(4):994-1025. doi: 10.3390/biom4040994. Biomolecules. 2014. PMID: 25412285 Free PMC article. Review. - Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
Li J, Feng X, Sun C, Zeng X, Xie L, Xu H, Li T, Wang R, Xu X, Zhou X, Zhou M, Zhou Y, Dan H, Wang Z, Ji N, Deng P, Liao G, Geng N, Wang Y, Zhang D, Lin Y, Ye L, Liang X, Li L, Luo G, Jiang L, Wang Z, Chen Q. Li J, et al. EBioMedicine. 2015 Jul 10;2(8):851-8. doi: 10.1016/j.ebiom.2015.07.004. eCollection 2015 Aug. EBioMedicine. 2015. PMID: 26425691 Free PMC article. Clinical Trial.
References
- J Biol Chem. 1995 Dec 15;270(50):29664-7 - PubMed
- FEBS Lett. 1995 Dec 4;376(3):155-8 - PubMed
- J Immunol. 1996 Apr 1;156(7):2361-4 - PubMed
- Arch Biochem Biophys. 1996 May 1;329(1):87-96 - PubMed
- Eur J Biochem. 1996 Jan 15;235(1-2):404-15 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous